SEC Form SC 13D/A filed by GreenLight Biosciences Holdings PBC (Amendment)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13D/A

(Rule 13d-101)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

§ 240.13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2(a)

(Amendment No. 1)*

Greenlight Biosciences Holdings, PBC
(Name of Issuer)

Common Stock, par value $0.0001 per share
(Title of Class of Securities)

39536G105
(CUSIP Number)

Continental Grain Company

767 Fifth Avenue, 15^th Floor

New York, NY 10153-0015

212-207-5100

Attention:

Michael Mayberry, General Counsel

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

July 24, 2023
(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-l(e), 240.13d-l(f) or 240.13d-l(g), check the following box. ☐

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240 13d-7 for other parties to whom copies are to be sent.

This Amendment No. 1 to the statement on Schedule 13D amends and supplements the statement on Schedule 13D filed by the Reporting Persons on June 8, 2023 (the “Original Schedule 13D”, and together with this Amendment No.1, the “Schedule 13D” or the “Statement”). Except as amended herein, the Original Schedule 13D remains in full force and effect. Terms defined in the Original Schedule 13D are used herein as so defined.

The information set forth in response to each separate Item below shall be deemed to be a response to all Items where such information is relevant.

Item 5. Interest in Securities of the Issuer.

Item 5(e) of the Original Schedule 13D is hereby amended and restated as follows:

(e) Date ceased to be a 5% owner. In connection with consummation of the Offer and the Merger in accordance with the Merger Agreement, on July 24, 2023, the Reporting Persons disposed of all previously reported shares of Common Stock pursuant to the Contribution and Exchange Agreement and ceased to beneficially own, or be part of a 13(d) group that beneficially owns, more than five percent of the Common Stock.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: July 26, 2023

5